Diabetes mellitus is the leading cause of end‐stage renal disease (ESRD) in the US and
many countries globally. The role of improved glycemic control in ameliorating the …

Chronically uncontrolled hyperglycemia is the leading cause of end stage kidney disease
(ESKD) necessitating dialysis. During times of transition to hemodialysis (HD) or peritoneal …

Resumen GOMEZ-HUELGAS, Ricardo y GRUPO DE TRABAJO PARA EL DOCUMENTO DE
CONSENSO SOBRE EL TRATAMIENTO DE LA DIABETES TIPO 2 EN EL PACIENTE CON …

Context: Size, encapsulation efficiency and stability affect the sustained release from
nanoparticles containing protein-type drugs. Objectives: Insulin was used to evaluate effects …

Objective: This review focuses on hypoglycemia in patients with end-stage renal disease
(ESRD). It discusses the pathophysiology of glucose metabolism in the kidney, the impact of …

Background and aims Diabetic kidney disease (DKD) is a major health issue that is
associated with an increased risk of morbidity and mortality. The treatment of DKD is …

Abstract Purpose of this Review Chronic diabetic nephropathy and renal dysfunction from
other causes are common in hospitalized patients with diabetes. Available diabetes …

The intraperitoneal route of administration accounts for less than 1% of insulin treatment
regimes in patients with diabetes mellitus type 1 (DM1). Despite being used for decades, a …

Diabetes is the commonest cause of end stage kidney disease globally, accounting for
almost 40% of new cases requiring renal replacement therapy. Management of diabetes in …

Diabetic kidney disease (DKD) is the most frequent cause of kidney failure (KF). There are
large variations in the incidence rates of kidney replacement therapy (KRT). Late referral to …